Lv7
3910 积分 2022-04-21 加入
Precision oncology in primary liver cancer: bridging the gap between molecular profiling and patient benefit
10天前
已关闭
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
17天前
已完结
Immune Checkpoint Inhibitor–Associated Myocarditis: Current Understanding of Clinical Presentation and Management
17天前
已完结
The global epidemiology of hepatocellular carcinoma
23天前
已完结
Hepatocellular carcinoma: Clinical trials to watch
1个月前
已完结
Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
1个月前
已完结
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
2个月前
已完结
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma
3个月前
已完结
Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma
3个月前
已完结
Real-life experience on the use of isavuconazole in solid organ transplantation
4个月前
已完结
皖公网安备34019202002308
